|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
|
SE523771C2
(sv)
*
|
1999-05-21 |
2004-05-18 |
Probi Ab |
Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
|
|
JP4343477B2
(ja)
*
|
2000-05-25 |
2009-10-14 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
ペットフード用新規プロバイオチックス
|
|
SE0003100D0
(sv)
|
2000-09-01 |
2000-09-01 |
Probi Ab |
New strains
|
|
SE0003576D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Probi Ab |
New strain
|
|
KR100419132B1
(ko)
*
|
2000-12-29 |
2004-02-18 |
조성근 |
위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
|
|
SE0103695D0
(sv)
|
2001-11-07 |
2001-11-07 |
Thomas Boren |
A novel non-antibiotic strategy against OGIP infections based on a cereal product
|
|
PT1485463E
(pt)
|
2002-03-21 |
2008-12-30 |
Bifodan As |
Estirpes de lactobacillus
|
|
JP4308481B2
(ja)
*
|
2002-06-18 |
2009-08-05 |
独立行政法人農業・食品産業技術総合研究機構 |
抗アレルギー剤
|
|
DK1565547T4
(da)
|
2002-06-28 |
2013-01-14 |
Biosearch S A |
Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
|
JPWO2004096246A1
(ja)
*
|
2003-03-13 |
2006-07-13 |
麒麟麦酒株式会社 |
抗アレルギー用組成物
|
|
CA2526861A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Axcan Pharma S.A. |
Lactobacillus fermentum strain and uses thereof
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
MY143693A
(en)
|
2004-03-24 |
2011-06-30 |
Nestec Sa |
Shelf stable product wih living micro-organisms
|
|
ITRM20040166A1
(it)
*
|
2004-03-31 |
2004-06-30 |
Alberto Cresci |
Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
|
|
US20080126195A1
(en)
*
|
2004-07-22 |
2008-05-29 |
Ritter Andrew J |
Methods and Compositions for Treating Lactose Intolerance
|
|
TW200637908A
(en)
*
|
2005-01-04 |
2006-11-01 |
Calpis Co Ltd |
Method for preparation of lactic acid bacterium having anti-allergic activity
|
|
EP2108269A1
(en)
|
2005-04-13 |
2009-10-14 |
Nestec S.A. |
Infant formula with low dose probiotics and low dose proteins
|
|
US20060263311A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Scavone Timothy A |
Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
|
|
BRPI0611492B1
(pt)
|
2005-05-31 |
2021-10-13 |
Mars, Incorporated |
Bifidobactéria probiótica felina
|
|
JP4938005B2
(ja)
|
2005-05-31 |
2012-05-23 |
ザ・アイムス・カンパニー |
ネコ科動物プロバイオティックであるラクトバシラス
|
|
EP1951273B1
(en)
*
|
2005-10-06 |
2014-02-12 |
Probi Ab |
Use of lactobacillus for treatment of autoimmune diseases
|
|
ES2381211T3
(es)
|
2006-02-15 |
2012-05-24 |
Nestec S.A. |
Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
|
|
ES2553636T3
(es)
|
2006-03-07 |
2015-12-10 |
Nestec S.A. |
Mezcla simbiótica
|
|
ATE478568T1
(de)
*
|
2007-02-02 |
2010-09-15 |
May Amadeus Alexander |
Produkt mit lebenden probiotischen mikroorganismen
|
|
CN101273737B
(zh)
*
|
2007-03-28 |
2011-08-24 |
哈尔滨正方科技有限公司 |
一种在常温下保持高活菌数的发酵乳饮料的制备方法
|
|
EP1974735A1
(en)
*
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Reduction of risk of diarrhoea
|
|
EP1974743A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics to Improve Gut Microbiota
|
|
DE602008005025D1
(de)
*
|
2007-07-06 |
2011-03-31 |
Nutricia Nv |
Verwendung von probiotika und ballaststoffen bei diarrhö
|
|
US20090110663A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Halow George M |
Method for treatment of bowel disorders
|
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
|
WO2009092628A1
(en)
|
2008-01-24 |
2009-07-30 |
Nestec S.A. |
Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
|
|
EP2265135B1
(en)
|
2008-03-14 |
2017-12-20 |
Nestec S.A. |
Synbiotic mixture
|
|
EP2127661A1
(en)
|
2008-05-27 |
2009-12-02 |
Nestec S.A. |
Probiotics to improve gut microbiotica
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
WO2010008491A2
(en)
*
|
2008-06-25 |
2010-01-21 |
Ritter Natural Sciences, Llc |
Lactose compositions with decreased lactose content
|
|
EP2147678A1
(en)
|
2008-07-21 |
2010-01-27 |
Nestec S.A. |
Probiotics to increase IgA secretion in infants born by caesarean section
|
|
PL2166083T3
(pl)
*
|
2008-12-31 |
2011-07-29 |
Syngen Biotech Co Ltd |
Nowy Lactobacillus paracasei SG96, zawierająca go kompozycja bakteriostatyczna oraz ich zastosowanie
|
|
US20100196341A1
(en)
*
|
2009-02-05 |
2010-08-05 |
Syngen Biotech Co., Ltd. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
|
|
WO2010098822A1
(en)
|
2009-02-24 |
2010-09-02 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
CA2761573A1
(en)
*
|
2009-05-11 |
2010-11-18 |
Nestec S.A. |
Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
US9226521B2
(en)
|
2009-12-08 |
2016-01-05 |
Nestec S.A. |
Infant formula with probiotics and milk fat globule membrane components
|
|
EP3202406A1
(en)
|
2010-04-28 |
2017-08-09 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
EP2510932A1
(en)
*
|
2011-04-15 |
2012-10-17 |
Nestec S.A. |
Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
|
|
WO2012177556A2
(en)
|
2011-06-20 |
2012-12-27 |
H.J. Heinz Company |
Probiotic compositions and methods
|
|
RU2654705C2
(ru)
|
2012-06-18 |
2018-05-22 |
Г.Дж. Хайнц Компани Брэндс ЛЛК |
Глютенозависимые расстройства
|
|
PT3470074T
(pt)
|
2013-05-10 |
2020-11-30 |
Heinz Co Brands H J Llc |
Probióticos
|
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
US10610546B2
(en)
|
2015-05-13 |
2020-04-07 |
Synlogic Operating Company Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
|
CN107208044B
(zh)
|
2014-12-05 |
2021-08-13 |
同生运营公司 |
被工程化为治疗与高氨血症相关的疾病的细菌
|
|
BR112017011923A2
(pt)
|
2014-12-05 |
2018-02-27 |
Synlogic Inc |
bactéria modificada para tratar doenças associadas com hiperamonemia
|
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
|
JP7095993B2
(ja)
|
2015-03-02 |
2022-07-05 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
|
|
EP3294757B1
(en)
|
2015-05-13 |
2023-12-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat a disease or disorder
|
|
EP3307879A2
(en)
|
2015-06-10 |
2018-04-18 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2016210378A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Multi-layered control of gene expression in genetically engineered bacteria
|
|
WO2017023818A1
(en)
|
2015-07-31 |
2017-02-09 |
Synlogic, Inc. |
Bacteria engineered to treat disorders involving propionate catabolism
|
|
EP3344266A1
(en)
|
2015-08-31 |
2018-07-11 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which oxalate is detrimental
|
|
US11685925B2
(en)
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017075485A1
(en)
|
2015-10-30 |
2017-05-04 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
|
|
WO2017074566A1
(en)
|
2015-10-30 |
2017-05-04 |
Dean Falb |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
EP3377518B1
(en)
|
2015-11-16 |
2022-04-13 |
Synlogic Operating Company, Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
|
WO2017123418A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
US11723932B2
(en)
|
2016-01-11 |
2023-08-15 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
WO2017123610A2
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to detoxify deleterious molecules
|
|
WO2017123592A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat disorders associated with bile salts
|
|
WO2017123676A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
|
|
WO2017136795A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with tryptophan metabolism
|
|
AU2017213646A1
(en)
|
2016-02-04 |
2018-08-23 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017139697A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
|
US11606965B2
(en)
*
|
2016-05-11 |
2023-03-21 |
Chr. Hansen A/S |
Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
|
|
AU2018205276A1
(en)
|
2017-01-06 |
2019-07-18 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
US10941433B2
(en)
|
2017-06-15 |
2021-03-09 |
Iowa State University Research Foundation, Inc. |
Neurotransmitter transport in probiotics
|
|
AU2018290278B2
(en)
|
2017-06-21 |
2022-12-15 |
Synlogic Operating Company, Inc. |
Bacteria for the treatment of disorders
|
|
EP3651782A1
(en)
|
2017-07-12 |
2020-05-20 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
US20210130806A1
(en)
|
2017-11-03 |
2021-05-06 |
Synlogic Operating Company, Inc. |
Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
|
|
CN110960559B
(zh)
*
|
2018-09-30 |
2021-02-26 |
内蒙古伊利实业集团股份有限公司 |
用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
|
|
EP3822338A4
(en)
|
2018-09-30 |
2021-08-18 |
Inner Mongolia Yili Industrial Group Co., Ltd. |
LACTOBACILLUS PARACASEI ET-22 AND ITS USE
|
|
KR20220003030A
(ko)
|
2019-04-29 |
2022-01-07 |
신로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
|
|
ES2983662T3
(es)
|
2019-07-23 |
2024-10-24 |
Frieslandcampina Nederland Bv |
Composición nutricional que comprende grasa láctea e inmunoglobulina
|
|
MX2022002949A
(es)
|
2019-09-24 |
2022-04-06 |
Prolacta Bioscience Inc |
Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
|
|
EP4081229A1
(en)
|
2019-12-24 |
2022-11-02 |
Iowa State University Research Foundation, Inc. |
Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading enzymes
|
|
CN113355252A
(zh)
*
|
2020-03-06 |
2021-09-07 |
南京卫岗乳业有限公司 |
一种副干酪乳杆菌及其应用
|
|
BR112022018571A2
(pt)
|
2020-03-20 |
2022-11-01 |
Synlogic Operating Co Inc |
Microrganismos manipulados para reduzir a hiperfenilalaninemia
|
|
IL300573A
(en)
|
2020-08-14 |
2023-04-01 |
Prolacta Bioscience Inc |
Breast milk oligosaccharide compositions for use with bacteriotherapy
|
|
AU2021393455A1
(en)
|
2020-12-02 |
2023-06-29 |
Synlogic Operating Company, Inc. |
Engineered microorganisms
|
|
CN116847860A
(zh)
|
2020-12-31 |
2023-10-03 |
同生运营公司 |
经工程化以减轻高苯丙氨酸血症的微生物
|
|
JP2024502629A
(ja)
|
2021-01-12 |
2024-01-22 |
プロラクタ バイオサイエンス，インコーポレイテッド |
シンバイオティック治療レジメン
|
|
CN112625983B
(zh)
*
|
2021-03-05 |
2021-05-28 |
山东中科嘉亿生物工程有限公司 |
一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
|
|
CN112877260B
(zh)
*
|
2021-03-30 |
2022-08-09 |
江南大学 |
一株缓解泻剂结肠的副干酪乳杆菌及其应用
|
|
EP4323385A1
(en)
|
2021-04-13 |
2024-02-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to secrete active proteins
|
|
CN115671144A
(zh)
*
|
2021-07-26 |
2023-02-03 |
锦乔生物科技有限公司 |
使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
|
|
WO2023044479A1
(en)
|
2021-09-17 |
2023-03-23 |
Synlogic Operating Company, Inc. |
Methods for reducing hyperphenylalaninemia
|
|
WO2023245171A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
WO2023245168A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
US20230414679A1
(en)
|
2022-06-22 |
2023-12-28 |
Iowa State University Research Foundation, Inc. |
Control of histamine to promote health and control enterocolitis using probiotic compositions
|
|
WO2023250478A1
(en)
|
2022-06-23 |
2023-12-28 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
|
|
WO2024081768A1
(en)
|
2022-10-12 |
2024-04-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
|
|
JP2025534764A
(ja)
|
2022-10-17 |
2025-10-17 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびｌ－アミノ酸デアミナーゼを発現する組み換え細菌
|
|
WO2024129974A1
(en)
|
2022-12-14 |
2024-06-20 |
Synlogic Operating Company, Inc. |
Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
|
|
WO2024130119A2
(en)
|
2022-12-16 |
2024-06-20 |
Prolacta Bioscience, Inc. |
Synbiotic compositions for short chain fatty acid production
|
|
EP4647439A1
(en)
|
2024-05-09 |
2025-11-12 |
Alma Mater Studiorum - Università di Bologna |
Non-pathogenic bacteria for delivery of ptd-fusion proteins
|